News & Articles

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.

The production agreement is part of AstraZeneca’s recently announced in-licensed programme with the University of Oxford

Increase the effectiveness of human vaccines against infectious diseases such as COVID-19

Dr. Fang Xie shares insights from his research into prostate cancer and offers hope of overcoming the growing problem of chemotherapy resistance to improve patient outcomes

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers

Company exploring further additional global capacity to provide broad and equitable access

Discover how you can boost your research with screen-printed and interdigitated electrodes

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics

LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients

This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy

The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications

Our expert webinar series aims to help you get the most from your drug discovery research

The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19

This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic

New version of their structure-based design platform aims to perform faster Free Energy Perturbation (FEP) calculations

Proving that the best thing comes in small packages, the compact chromatograph aims to deliver reliable performance

Deal enables a wider suite of pre-clinical testing services in oncology

Watch this on-demand webinar to learn about the applications for cell-based therapies and biologics using advanced high-throughput flow cytometry

The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients

A rare lung disease drug is being trialed to help fight COVID-19

The study is expected to begin enrolling in June with a target of approximately 450 patients globally

Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels